Ezetimibe Inhibit Hyperacetylation of SREBP-1c in Lipid-Loaded Cells Derived from VSMC Required for SIRT1

ZHANG Chi,HUANG Liang,LUO Qi-Fu,QU Shun-Lin,WEI Xing,TANG Zhi-Han,GAO Zhi-Ping

2012-01-01

Abstract:AimThe effect of ezetimibe(EZE) on acetylation of sterol regulatory element binding protein-1c(SREBP-1c) in lipid-loaded cells derived from vascular smooth muscle cell(VSMC) and its mechanisms have been explored.Methods The cholesterol∶methyl-β-cyclodextrin(Chol∶MβCD) complexes were used to build VSMC-derived lipid-loaded cells.After treated by 30 μmol/L EZE,the level of acetylated SREBP-1c,the level of fatty acid synthase(FAS) protein expression in lipid-loaded cells were detected by western blot,and the interaction between SIRT1 and SREBP-1c were analyzed by co-immunoprecipitation,and the role of SIRT1 in deacetylation of SREBP-1c was investigated using shRNA-mediated protein knockdown.Results The level of acetylated SREBP-1c,the level of FAS protein expression were increased,but the interaction between SIRT1 and SREBP-1c was significantly reduced in lipid-loaded cells.However,EZE could weaken all these effects induced by Chol∶MβCD in lipid-loaded cells.A further study reveals that effects of EZE in lipid-loaded cells could be abolished by SIRT1 shRNA transfection.ConclusionEZE inhibits hyperacetylation of SREBP-1c in lipid-loaded cells required for SIRT1.